auditor . The results of operations are as follows . The Company's performance For six months As of June 30, 2018, the Company had a net loss of Baht 30.80 million, compared with the same period of the

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

by Certified Public Accountant as follows: 1. Total revenues were Baht 1,108.92 million, an increase of Baht 691.90 million or 165.92% from the same period of last year. This was due to the following

of Global Connections Public Co., Ltd. (GC) for the three-month period ended 30 September 2018 which had been reviewed by the Independent Auditor and would like to clarify more details on the Interim

of Global Connections Public Co., Ltd. (GC) for the three-month period ended 30 June 2020 which had been reviewed by the Independent Auditor and would like to clarify more details on the Interim

. An increase in revenue from sales amount THB 96.6 MB, equivalent to 56.0% of total revenue from sales. The company has a higher gross margin comparing to the same period from 12.3% to 15.4% because the

businesses in banking and insurance sector began to bring technology into the business operations resulting in a significant increase in revenue compared with the same period of last year. Revenue from

32.00 million from Wisdom Tree Investment (S) PTE. Limited, which the Company recognized the net loss sharing Baht 24.66 million, comparing with the same period of previous year, which the Company

% Total comprehensive income (loss) attributable to owners of the parent Operating Profit (Loss) EBIT Net Profit (Loss) Total Comprehensive income for ther period Revenue from transmission and

-9320 1 Ref: PCL 2020/018 November 14, 2020 Subject: Management Discussion and Analysis for the 9-month period ended 30 September 2020 To: The President of the Stock Exchange of Thailand Panjawattana